BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23613672)

  • 1. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma.
    Park KW; Jung ES; Kim DG; Yoo YK; Hong TH; Lee IS; Koh YH; Kim JH; Lee MA
    Cancer Res Treat; 2013 Mar; 45(1):63-9. PubMed ID: 23613672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.
    Won HS; Lee MA; Chung ES; Kim DG; You YK; Hong TH; Lee IS
    BMC Cancer; 2010 Oct; 10():564. PubMed ID: 20955617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact.
    Kobayashi S; Wada H; Tomokuni A; Takahashi H; Gotoh K; Sakon M; Mori M; Doki Y; Eguchi H
    Langenbecks Arch Surg; 2020 Nov; 405(7):989-998. PubMed ID: 32812064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma.
    Shirai K; Ebata T; Oda K; Nishio H; Nagasaka T; Nimura Y; Nagino M
    World J Surg; 2008 Nov; 32(11):2395-402. PubMed ID: 18795245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
    Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
    Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.
    Kuroda Y; Aishima S; Taketomi A; Nishihara Y; Iguchi T; Taguchi K; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Jul; 38(7):1014-1022. PubMed ID: 17391729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
    Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Capelli P; Pedica F; Nicoli P; Conci S; Iacono C
    J Surg Oncol; 2010 Feb; 101(2):111-5. PubMed ID: 19953578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.